(5R)-3-(4-溴-3-氟苯基)-5-羟甲基恶唑烷-2-酮 ,特地唑胺中间体(泰地唑胺), 99%,(R)-3-(4-Bromo-3-fluorophenyl)-5-(hydroxymethyl)oxazolidin-2-one
产品编号:西域试剂-WR152136| CAS NO:444335-16-4| MDL NO:MFCD08166353 | 分子式:C10H9BrFNO3 | 分子量:290.09
本网站销售的所有产品仅用于工业应用或者科学研究等非医疗目的,不可用于人类或动物的临床诊断或者治疗,非药用,非食用,
| 英文名称 | (R)-3-(4-Bromo-3-fluorophenyl)-5-(hydroxymethyl)oxazolidin-2-one |
|---|---|
| CAS编号 | 444335-16-4 |
| 产品沸点 | 401.6±35.0 °C at 760 mmHg |
| 产品密度 | 1.7±0.1 g/cm3 |
| 产品闪点 | 196.7±25.9 °C |
| 精确质量 | 288.974976 |
| PSA | 49.77000 |
| LogP | 1.87 |
| 蒸气压 | 0.0±1.0 mmHg at 25°C |
| 折射率 | 1.590 |
相关文档
化学品安全说明书(MSDS)
下载MSDS质检证书(COA)
相关产品
| 海关编码 | 2934999090 |
|---|
|
~89%
444335-16-4 |
| 文献:LegoChem Biosciences, Inc.; CHO, Young Lag; BAEK, Sung Yoon; CHAE, Sang Eun; KIM, Sun Young; LEE, Hong Bum; LEE, Hyang Sook; OH, Kyuman; HEO, Hye Jin; PARK, Tae Kyo; WOO, Sung Ho; KIM, Yong Zu Patent: EP2692727 A2, 2014 ; Location in patent: Paragraph 0161-0162 ; |
|
~%
444335-16-4 |
| 文献:GLOBAL ALLIANCE FOR TB DRUG DEVELOPMENT Patent: WO2009/120789 A1, 2009 ; Location in patent: Page/Page column 58 ; |
|
~%
444335-16-4 |
| 文献:Gordeev, Mikhail F.; Patel, Dinesh V.; Barbachyn, Michael R.; Gage, James R. Patent: US2003/13737 A1, 2003 ; |
|
~%
444335-16-4 |
| 文献:LegoChem Biosciences, Inc.; CHO, Young Lag; BAEK, Sung Yoon; CHAE, Sang Eun; KIM, Sun Young; LEE, Hong Bum; LEE, Hyang Sook; OH, Kyuman; HEO, Hye Jin; PARK, Tae Kyo; WOO, Sung Ho; KIM, Yong Zu Patent: EP2692727 A2, 2014 ; |
| 上游产品 6 | |
|---|---|
| 下游产品 1 | |
![(5S)-N-[3-(4-溴-3-氟苯基)-2-氧代-5-恶唑烷基甲基]乙酰胺结构式](/20230522/856677-05-9.png)

浙公网安备 33010802013016号